| Haplo | MUD10/10 | MMUD 9/10 | MUD 10/10 vs Haplo | MMUD 9/10 vs Haplo |
---|---|---|---|---|---|
No. | 265 | 2490 | 813 | Â | Â |
Follow-up | 34.2 (3–84) | 35.7 (1–103) | 35.8 (1–102) | 0.93 | 0.72 |
Age | 42.8 (18–75) | 47.0 (18–76) | 44.8 (18–71) | <10–3 | 0.017 |
Year of Tx | 2011 (07–13) | 2010 (07–13) | 2010 (07–13) | <10–3 | <10–3 |
Diagnosis to transplant | 260 days (82–5784) | 196 days (71–5793) | 223d (73–4452) | <10–3 | 0.016 |
Diagnosis | |||||
 AML | 176 | 1645 | 510 |  |  |
66% | 66% | 63% | Â | Â | |
 ALL | 89 | 845 | 303 | 0.90 | 0.28 |
34% | 34% | 37% | Â | Â | |
Disease status | |||||
 CR1 | 159 | 1901 | 580 |  |  |
60% | 76% | 71% | Â | Â | |
 CR2 | 106 | 589 | 233 | <10–3 | 0.001 |
40% | 24% | 29% | Â | Â | |
Patient sex | |||||
 Male | 155 | 1344 | 442 |  |  |
58% | 54% | 54% | Â | Â | |
 Female | 110 | 1146 | 371 | 0.16 | 0.24 |
42% | 46% | 46% | Â | Â | |
Donor sex | |||||
 Male | 139 | 1782 | 490 |  |  |
52% | 72% | 61% | Â | Â | |
 Female | 126 | 690 | 312 | <10–3 | 0.013 |
48% | 28% | 39% | Â | Â | |
Female to male | |||||
 No | 191 | 2186 | 659 |  |  |
72% | 88% | 82% | Â | Â | |
 Yes | 74 | 286 | 143 | <10–3 | <10–3 |
28% | 12% | 18% | Â | Â | |
CMV neg to neg | |||||
 No | 225 | 1673 | 577 |  |  |
86% | 69% | 73% | Â | Â | |
 Yes | 36 | 754 | 212 | <10–3 | <10–3 |
14% | 31% | 27% | Â | Â | |
Cytogenetics | |||||
 Good | 29 | 261 | 68 |  |  |
11% | 10% | 8% | Â | Â | |
 Intermediate | 168 | 1398 | 446 |  |  |
63% | 56% | 55% | Â | Â | |
 Poor | 68 | 831 | 299 | 0.04 | 0.004 |
26% | 33% | 37% | Â | Â |